Nuclear Receptor NR1D1 Regulates Abdominal Aortic Aneurysm Development by Targeting the Mitochondrial Tricarboxylic Acid Cycle Enzyme Aconitase-2
Ling-Yue SunYu-Yan LyuHeng-Yuan ZhangZhi ShenGuan-Qiao LinNa GengYu-Li WangLin HuangZe-Hao FengXiao GuoNan LinSong DingAn-Cai YuanLan ZhangKun QianJun PuState Key Laboratory for Oncogenes and Related Genes,Department of Cardiology,Shanghai Jiao Tong University,Shanghai,China. (L.-Y.S.,Y.-Y.L.,H.-Y.Z.,Z.S.,G.-Q.L.,N.G.,Z.-H.F.,X.G.,N.L.,S.D.,A.-C.Y.,J.P.)Department of Vascular Surgery,Shanghai Jiao Tong University,Shanghai,China. (Y.-L.W.,L.Z.)Renji Hospital,School of Medicine,School of Biomedical Engineering and Med-X Research Institute,Shanghai Jiao Tong University,Shanghai,China. (L.H.,K.Q.)
DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.057623
IF: 37.8
2022-07-28
Circulation
Abstract:Metabolic disorder increases the risk of abdominal aortic aneurysm (AAA). NRs (nuclear hormone receptors) have been increasingly recognized as important regulators of cell metabolism. However, the role of NRs in AAA development remains largely unknown. We analyzed the expression profile of the NR superfamily in AAA tissues and identified NR1D1 (NR subfamily 1 group D member 1) as the most highly upregulated NR in AAA tissues. To examine the role of NR1D1 in AAA formation, we used vascular smooth muscle cell (VSMC)–specific, endothelial cell–specific, and myeloid cell–specific conditional Nr1d1 knockout mice in both AngII (angiotensin II)– and CaPO 4 -induced AAA models. Nr1d1 gene expression exhibited the highest fold change among all 49 NRs in AAA tissues, and NR1D1 protein was upregulated in both human and murine VSMCs from AAA tissues. The knockout of Nr1d1 in VSMCs but not endothelial cells and myeloid cells inhibited AAA formation in both AngII- and CaPO 4 -induced AAA models. Mechanistic studies identified ACO2 (aconitase-2), a key enzyme of the mitochondrial tricarboxylic acid cycle, as a direct target trans-repressed by NR1D1 that mediated the regulatory effects of NR1D1 on mitochondrial metabolism. NR1D1 deficiency restored the ACO2 dysregulation and mitochondrial dysfunction at the early stage of AngII infusion before AAA formation. Supplementation with αKG (α-ketoglutarate, a downstream metabolite of ACO2) was beneficial in preventing and treating AAA in mice in a manner that required NR1D1 in VSMCs. Our data define a previously unrecognized role of nuclear receptor NR1D1 in AAA pathogenesis and an undescribed NR1D1-ACO2 axis involved in regulating mitochondrial metabolism in VSMCs. It is important that our findings suggest αKG supplementation as an effective therapeutic approach for AAA treatment.
cardiac & cardiovascular systems,peripheral vascular disease